1 – 31 of 31
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
The Vitamin D Receptor as a Prognostic Marker in Breast Cancer-A Cohort Study
(
- Contribution to journal › Article
-
Mark
High Caveolin-1 mRNA expression in triple-negative breast cancer is associated with an aggressive tumor microenvironment, chemoresistance, and poor clinical outcome
(
- Contribution to journal › Article
-
Mark
The prognostic value of programmed death-ligand 1 (PD-L1) expression in resected colorectal cancer without neoadjuvant therapy - differences between antibody clones and cell types
(
- Contribution to journal › Article
- 2022
-
Mark
PRR11 unveiled as a top candidate biomarker within the RBM3-regulated transcriptome in pancreatic cancer
(
- Contribution to journal › Article
- 2021
-
Mark
The Prognostic Impact of Intratumoral Aryl Hydrocarbon Receptor in Primary Breast Cancer Depends on the Type of Endocrine Therapy : A Population-Based Cohort Study
(
- Contribution to journal › Article
- 2020
-
Mark
Lymphocyte antigen 6 superfamily member D is a marker of urothelial and squamous differentiation : Implications for risk stratification of bladder cancer
(
- Contribution to journal › Article
-
Mark
Patient Characteristics Influence Activated Signal Transducer and Activator of Transcription 3 (STAT3) Levels in Primary Breast Cancer—Impact on Prognosis
(
- Contribution to journal › Article
-
Mark
CYP27A1 expression is associated with risk of late lethal estrogen receptor-positive breast cancer in postmenopausal patients
(
- Contribution to journal › Article
-
Mark
Tumor-Associated CD68+, CD163+, and MARCO+ Macrophages as Prognostic Biomarkers in Patients With Treatment-Naïve Gastroesophageal Adenocarcinoma
(
- Contribution to journal › Article
- 2019
-
Mark
Discovery of KIRREL as a biomarker for prognostic stratification of patients with thin melanoma 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis
(
- Contribution to journal › Article
-
Mark
Clinical impact of T cells, B cells and the PD-1/PD-L1 pathway in muscle invasive bladder cancer : a comparative study of transurethral resection and cystectomy specimens
(
- Contribution to journal › Article
-
Mark
Clinical significance of stromal ER and PR expression in periampullary adenocarcinoma
(
- Contribution to journal › Article
- 2018
-
Mark
Expression of programmed cell death protein 1 (PD-1) and its ligand PD-L1 in colorectal cancer : Relationship with sidedness and prognosis
(
- Contribution to journal › Article
-
Mark
Translational study reveals a two-faced role of RBM3 in pancreatic cancer and suggests its potential value as a biomarker for improved patient stratification
(
- Contribution to journal › Article
- 2017
-
Mark
The prognostic impact of COX-2 expression in breast cancer depends on oral contraceptive history, preoperative NSAID use, and tumor size
(
- Contribution to journal › Article
-
Mark
Podocalyxin-like and rna-binding motif protein 3 are prognostic biomarkers in urothelial bladder cancer : A validatory study
(
- Contribution to journal › Article
-
Mark
Androgen Receptor in Stage I-II Primary Breast Cancer -Prognostic Value and Distribution in Subgroups
(
- Contribution to journal › Article
-
Mark
The clinical impact of tumour-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite : A cohort study
(
- Contribution to journal › Article
- 2016
-
Mark
Expression of podocalyxin-like protein is an independent prognostic biomarker in resected esophageal and gastric adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Significant association and synergistic adverse prognostic effect of podocalyxin-like protein and epidermal growth factor receptor expression in colorectal cancer
(
- Contribution to journal › Article
-
Mark
Prognostic impact of tumour-associated B cells and plasma cells in oesophageal and gastric adenocarcinoma
(
- Contribution to journal › Article
- 2014
-
Mark
Prognostic and treatment predictive significance of SATB1 and SATB2 expression in pancreatic and periampullary adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Reduced expression of the polymeric immunoglobulin receptor in pancreatic and periampullary adenocarcinoma signifies tumour progression and poor prognosis
(
- Contribution to journal › Article
-
Mark
Expression and prognostic significance of the polymeric immunoglobulin receptor in epithelial ovarian cancer
(
- Contribution to journal › Article
- 2013
-
Mark
Clinicopathological correlates and prognostic significance of KRAS mutation status in a pooled prospective cohort of epithelial ovarian cancer
(
- Contribution to journal › Article
-
Mark
Sex differences in the prognostic significance of KRAS codons 12 and 13, and BRAF mutations in colorectal cancer: a cohort study
(
- Contribution to journal › Article
- 2012
-
Mark
Expression of the global regulator SATB1 is an independent factor of poor prognosis in high grade epithelial ovarian cancer
(
- Contribution to journal › Article
-
Mark
Discovery of Dachshund 2 protein as a novel biomarker of poor prognosis in epithelial ovarian cancer
(
- Contribution to journal › Article
-
Mark
A cohort study of the prognostic and treatment predictive value of SATB2 expression in colorectal cancer
(
- Contribution to journal › Article
- 2011
-
Mark
High nuclear RBM3 expression is associated with an improved prognosis in colorectal cancer
(
- Contribution to journal › Article
-
Mark
Effects of radiation therapy on tissue and serum concentrations of tumour associated trypsin inhibitor and their prognostic significance in rectal cancer patients
(
- Contribution to journal › Article